MIRMirion Technologies, Inc.
$16.63-32% 1Y
$16.63
$14.1352 weeks$29.75
The financials
Mirion Technologies, Inc. by the numbers
Mirion Technologies, Inc. (MIR) reported revenue of $267M in Q2 2026 (quarter ended Jun 30, 2026), up 20% from the same quarter a year earlier. That came with a gross margin of 50% and net income of $7.7M (2.9% of revenue). For the full year FY2025, revenue was $925M (+7.5% year on year) and net income $29M. Its largest product in Q2 2026 was Nuclear Power at $118M, 44% of the disclosed total, well ahead of Cancer Care at 24%. The next results filing is expected around Oct 27, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $267M | $223M | +20% |
| Gross profit | $133M | $103M | +30% |
| Operating income | $18M | $9.9M | +81% |
| Net income | $7.7M | $8.3M | −7.2% |
| Diluted EPS | $0.03 | $0.03 | 0.0% |
| Product | Revenue | Share |
|---|---|---|
| Nuclear Power | $118M | 44% |
| Cancer Care | $63M | 24% |
| Other Research | $39M | 15% |
| Labs And Research | $29M | 11% |
| Other Care | $18M | 6.7% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $266.8M (+3.6%)
Nuclear Power grew +44% year on yearOther Care -6.3% year on year
Segment Latestquarter on quarteryear on year
- Nuclear Power$118.1M$118.1Mquarter on quarter -6.1%year on year +44%-6.1%+44%
- Cancer Care$62.8M$62.8Mquarter on quarter +14%year on year +0.96%+14%+0.96%
- Other Research$39.0M$39.0Mquarter on quarter +24%year on year +21%+24%+21%
- Labs And Research$29.1M$29.1Mquarter on quarter +2.8%year on year +6.2%+2.8%+6.2%
- Other Care$17.8M$17.8Mquarter on quarter +6.0%year on year -6.3%+6.0%-6.3%
Specialty Industrial Machinery
Ranks #29 of 33 by RyuScore